Incyte Corp (NASDAQ: INCY) flaunted slowness of -0.47% at $100.44, as the Stock market unbolted on Wednesday, before settling in for the price of $100.91 at the close. Taking a more long-term approach, INCY posted a 52-week range of $53.56-$109.28.
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded -40.36%. Meanwhile, its Annual Earning per share during the time was -40.36%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 523.86%. This publicly-traded company’s shares outstanding now amounts to $196.13 million, simultaneously with a float of $194.30 million. The organization now has a market capitalization sitting at $19.72 billion. At the time of writing, stock’s 50-day Moving Average stood at $98.73, while the 200-day Moving Average is $78.29.
Incyte Corp (INCY) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Incyte Corp industry. Incyte Corp’s current insider ownership accounts for 1.03%, in contrast to 103.65% institutional ownership. According to the most recent insider trade that took place on Dec 19 ’25, this organization’s Principal Accounting Officer sold 2,774 shares at the rate of 100.00, making the entire transaction reach 277,400 in total value, affecting insider ownership by 22,973. Preceding that transaction, on Dec 18 ’25, Company’s Principal Accounting Officer sold 600 for 98.25, making the whole transaction’s value amount to 58,950. This particular insider is now the holder of 22,973 in total.
Incyte Corp (INCY) Earnings and Revenue Records
Incyte Corp’s EPS increase for this current 12-month fiscal period is 523.86% and is forecasted to reach 7.74 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 105.04% through the next 5 years, which can be compared against the -40.36% growth it accomplished over the previous five years trading on the market.
Incyte Corp (NASDAQ: INCY) Trading Performance Indicators
Let’s observe the current performance indicators for Incyte Corp (INCY). It’s Quick Ratio in the last reported quarter now stands at 3.13. Alongside those numbers, its PE Ratio stands at $16.85, and its Beta score is 0.82. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 4.10. Similarly, its price to free cash flow for trailing twelve months is now 16.47.
In the same vein, INCY’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 5.96, a figure that is expected to reach 1.93 in the next quarter, and analysts are predicting that it will be 7.74 at the market close of one year from today.
Technical Analysis of Incyte Corp (INCY)
Now, what If we examine the latest scores posted by [Incyte Corp, INCY]. During the last 5-days, its volume was better the volume of 1.96 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 72.12% While, its Average True Range was 53.44.
Raw Stochastic average of Incyte Corp (INCY) in the period of the previous 100 days is set at 73.08%, which indicates a major rise in contrast to 68.05% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 3.16 that was higher than 2.64 volatility it exhibited in the past 100-days period.
